“…For human ALF, the following ABS w e r e u s e d : S P -A ( s c -1 6 6 9 1 4 , S a n t a C r u z Biotechnology, Inc.), SP-D (sc-59695, Santa Cruz Biotechnology, Inc.), C2 (sc-134639, Santa Cruz Biotechnology, Inc.), C3 (sc-28294/B9, Santa Cruz Biotechnology, Inc.), C5 (A220, Complement Technology, Inc., www.complementtech.com), and C7 (sc-160195, Santa Cruz Biotechnology, Inc.). Western blotting (WB) to detect SP-A, SP-D, and complement components and to determine the presence of nitrotyrosine and carbonyl residues were performed following the manufacturer's recommendations and established methods (Bolger et al 2007;Clay et al 2008). The carbonyl and nitrotyrosine presence was determined assessing the band density of all bands in the lane.…”